CITIUS PHARMACT Revenue, Profits - CTXR Annual Income Statement

Add to My Stocks
$1.48 $0.13 (9.63%) CTXR stock closing price Sep 19, 2018 (Closing)

Looking at financial statements, along with the CITIUS PHARMACT stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the CTXR stock is bound to reflect the impact of the YOY decline of 0. The CITIUS PHARMACT profit and loss statement for 2017 shows a net profit of $-10.38M. Profits for last year was $-8.29M. Apart from this an investor should also check CITIUS PHARMACT assets and CITIUS PHARMACT free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Oct - Sep2017201620152014
CITIUS PHARMACT Revenues or Net Sales
Cost Of Goods Sold (COGS)----
Research & Development Expense2.93M2.93M1.79M-
Selling General & Admin Expense7.05M4.51M1.43M-
Income Before Depreciation Depletion Amortization-9.98M-7.44M-3.22M-0.65M
Depreciation Depletion Amortization----
Non Operating Income--0.83M--
Interest Expense----
Provision for Income Taxes----
Investment Gains Losses----
Other Income----
Income Before Extraordinaries & Disc Operations-10.38M-8.29M-2.9M-0.73M
Extraordinary Items & Discontinued Operations----
CITIUS PHARMACT Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS----
Average Shares used to compute Basic EPS----
Income Before Nonrecurring Items----
Income from Nonrecurring Items----
CITIUS PHARMACT Earnings Per Share Basic Net
CITIUS PHARMACT Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items----
Preferred Dividends Acc Pd----
Dividends Common----
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing CITIUS PHARMACT stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: CITIUS PHARMACT revenue chart implies that the company is growing. It has not been the case with CITIUS PHARMACT. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like CITIUS PHARMACT try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The CTXR financials along with CITIUS PHARMACT historical stock prices provide a lot of details about the firm.

CITIUS PHARMACT Income Statement - Key Financial Ratios